Comparing yoga and physiotherapy for sarcoidosis treatment
Comparison of the Effects of Yoga and Conventional Physiotherapy Programs on Fatigue, Pulmonary Functions and Exercise Capacity in Patients With Sarcoidosis
This study is testing whether yoga or traditional physiotherapy helps people with sarcoidosis improve their lung function and feel better overall.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 32 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Saglik Bilimleri Universitesi Academic / other |
| Locations | 1 site (Istanbul, Maltepe) |
| Trial ID | NCT06848608 on ClinicalTrials.gov |
What this trial studies
This study compares the effects of yoga and conventional physiotherapy programs on patients diagnosed with sarcoidosis, particularly focusing on those with pulmonary involvement and fatigue symptoms. The trial aims to assess improvements in lung capacity, inspiratory muscle strength, and overall quality of life through these non-pharmacological interventions. Participants will be divided into two groups, one receiving traditional physiotherapy and the other engaging in a structured yoga program. The study seeks to fill a gap in the literature regarding non-drug treatments for sarcoidosis, which is often associated with significant emotional and physical challenges.
Who should consider this trial
Good fit: Ideal candidates for this study are adults diagnosed with stage II-III-IV sarcoidosis who experience fatigue and have pulmonary involvement.
Not a fit: Patients with cognitive impairments, major cardiovascular diseases, or those currently experiencing disease exacerbations may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide patients with effective non-pharmacological treatment options to improve their quality of life and manage symptoms of sarcoidosis.
How similar studies have performed: While studies on non-pharmacological treatments for sarcoidosis are limited, there is evidence suggesting that exercise training can significantly improve outcomes in chronic lung diseases, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being diagnosed with Sarcoidosis by a physician (Stage II-III-IV) * Pulmonary involvement * Having fatigue symptoms (FAS ≥22 points) * No immunosuppressive drug use for the last 1 year * No antidepressant use for the last 6 months Exclusion Criteria: * Presence of cognitive impairment that prevents communication * Anemia * Uveitis * Diabetes * Pregnancy * Major cardiovascular diseases * Fractures * Osteoporosis * Those who have a neurological or orthopedic disease that will affect the treatment * Those who are in the exacerbation period of the disease * Tumor
Where this trial is running
Istanbul, Maltepe
- Süreyyapaşa Chest Diseases and Chest Surgery Training and Research Hospital — Istanbul, Maltepe, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Şeyda YILDIZ, PhD(c), PT
- Email: yildizseydaa@gmail.com
- Phone: +905378484687
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.